Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;14(15):e2405106.
doi: 10.1002/adhm.202405106. Epub 2025 May 13.

Chondrogenic Potential of Cryopreserved Aortic Allografts: Guiding Perichondrial Regeneration in Tracheal Repair

Affiliations

Chondrogenic Potential of Cryopreserved Aortic Allografts: Guiding Perichondrial Regeneration in Tracheal Repair

Wan-Ting Hung et al. Adv Healthc Mater. 2025 Jun.

Abstract

Native tracheal cartilage exhibits limited regenerative capacity, making the search for suitable biomaterials for tracheal repair a persistent challenge. In this study, a non-decellularized cryopreserved aortic allograft (CAo) is investigated as a scaffold for tracheal cartilage regeneration. Originally used to reconstruct infected aortas, CAo retains key features of a large artery-abundant elastic fibers and smooth muscle cells-and demonstrates favorable in vitro biocompatibility with chondrocytes. A trachea-CAo patch construct maintains tensile properties comparable to native trachea and tolerates normal expiratory forces. In a rabbit patch-defect model, CAo elicits only a mild-to-moderate immune response that gradually subsides. Within one month of implantation, robust neocartilage formation is observed, along with angiogenesis and epithelial regeneration. Over the next 12 months, the original aortic scaffold progressively degrades, while newly formed cartilage-originating from recipient perichondrial chondroprogenitor cells-replaces it. Proteomic analyses show that CAo is enriched in cytoskeletal, adhesion, cell migration, and extracellular matrix (ECM)-related proteins, with fibroblast growth factor 2 emerging as a critical mediator of chemotaxis and chondrogenic differentiation. These findings indicate that CAo serves as both a structural and biological scaffold, activating tracheal cartilage regeneration through synergistic biocompatibility, growth factor signaling, and ECM support.

Keywords: biological scaffolds; chondrogenesis; cryopreserved aortas; extracellular matrices; fibroblast growth factors; perichondria; tracheae.

PubMed Disclaimer

References

    1. L. Soriano, T. Khalid, D. Whelan, N. O'Huallachain, K. C. Redmond, F. J. O'Brien, C. O'Leary, S.‐A. Cryan, European Respiratory Review 2021, 30, 210154.
    1. A. A. Abouarab, H. H. Elsayed, H. Elkhayat, A. Mostafa, D. C. Cleveland, A. E. Nori, Ann. Thorac. Cardiovasc Surg. 2017, 23, 66.
    1. A. M. Greaney, L. E. Niklason, Tissue Eng., Part B 2021, 27, 341.
    1. H. C. Grillo, Surgery of the Trachea and Bronchi, B. C. Decker, Hamilton, Ontario, Canada, 2003.
    1. S. Haykal, M. Salna, T. K. Waddell, S. O. Hofer, Plastic and Reconstructive Surgery Global Open 2014, 2, e178.

LinkOut - more resources